Evaxion A (EVAX) Current Leases (2019 - 2025)
Evaxion A (EVAX) reported Current Leases of $360000.0 for Q4 2025, up 14.65% on a YoY basis from $314000.0 in Q4 2024, and up 1.12% quarter-over-quarter from $356000.0 in Q2 2025.
Evaxion A (EVAX) Current Leases (2019 - 2025) Analysis & Trends
Evaxion A has reported Current Leases for 7 years, with the latest figure at $360000.0 in Q4 2025.
- For the quarter ending Q4 2025, Current Leases rose 14.65% year-over-year to $360000.0; the trailing twelve-month figure through Dec 2025 stood at $360000.0 (up 14.65% YoY), and the FY2025 full-year result was $360000.0, up 14.65% from the prior year.
- Current Leases for Q4 2025 stood at $360000.0, up from $356000.0 in the prior quarter.
- The five-year high for Current Leases was $2.3 million in Q3 2021, with the low at $292000.0 in Q2 2022.
- Historically, Current Leases has averaged $579000.0 across 5 years, with a median of $319000.0 in 2024.
- Annual changes were most pronounced in 2021 — Current Leases jumped 1470.0% — and 2022, when it plunged 70.47%.
- Evaxion A's Current Leases stood at $314000.0 in 2021, then slipped by 3.5% to $303000.0 in 2022, then climbed by 7.59% to $326000.0 in 2023, then declined by 3.68% to $314000.0 in 2024, then climbed by 14.65% to $360000.0 in 2025.
- The last three Current Leases figures came in at $360000.0 (Q4 2025), $356000.0 (Q2 2025), and $314000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 720.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 360,000.00 |
| Jun 30, 2025 | 356,000.00 |
| Dec 31, 2024 | 314,000.00 |
| Jun 30, 2024 | 319,000.00 |
| Dec 31, 2023 | 326,000.00 |
| Jun 30, 2023 | 318,000.00 |
| Dec 31, 2022 | 303,000.00 |
| Jun 30, 2022 | 292,000.00 |
| Mar 31, 2022 | 311,000.00 |
| Dec 31, 2021 | 314,000.00 |
| Sep 30, 2021 | 2.29 Mn |
| Jun 30, 2021 | 974,000.00 |
| Mar 31, 2021 | 1.05 Mn |
| Dec 31, 2020 | 20,000.00 |
| Dec 31, 2019 | 36,000.00 |